This study showed that high nuclear expression of HIF-1α and high cytoplasmic expression of HIF-2α indicate unfavorable prognosis in patients with RCC, which may potentially serve as risk stratification markers and even therapeutic targets to manage this disease. This evidence concerns the gene EPAS1 and renal cell carcinoma.